Profile
| Metric | Value |
|---|---|
| Full Name | Quoin Pharmaceuticals, Ltd. |
| Ticker | NASDAQ: QNRX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | quoinpharma.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $13.85 | |
| Price, 1D Change | +0.73% | |
| $8M | ||
| - | ||
| - | ||
| -0.51 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$67.17 | ||
| EPS, 1Y Change | -598.42% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | APOP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$67.17 | ||
| EPS Estimate | N/A | -$11.60 |
| EPS Est. Change | N/A | +82.73% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $13.85 | |
| Price Target | - | $27.00 |
| Price Tgt. Change | - | +94.95% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$9.47 | -$9.62 | -1.55% | |
| -$2.05 | -$67.17 | -3,176.45% | |
| -$11.60 | N/A | +82.73% | |
| -$5.55 | N/A | +91.74% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $13.85 | |
| $9.78 | ||
| SMA 200 vs Price | -29.35% | |
| $14.19 | ||
| SMA 50 vs Price | +2.48% | |
| -0.51 | ||
| $1.56 | ||
| 48.52 | ||
| 61.62% | ||
| 198.92% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$67.17 | ||
| -$100.50K | ||
| - | ||
| -$9.57M | ||
| - | ||
| -$9.01M | ||
| - | ||
| -$9.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.57 | ||
| 3.57 | ||
| - | ||
| - | ||
| -5.36 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -6.71 | ||
| -0.19 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $9.20M | ||
| $14.06M | ||
| $15.71M | ||
| $14.93M | ||
| $6.50M | ||
| $4.18M | ||
| $0.00 | ||
| $0.00 | ||
| $905.70K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $9.01M | ||
| $9.47M | ||
| $100.50K | ||
| $0.00 | ||
| $100.50K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$7.89M | ||
| -$1.90M | ||
| $11.02M | ||
| $0.00 | ||
| -$7.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Alliance Global Partners | ||
| Ladenburg Thalmann | ||
| Maxim Group | ||
| JMP Securities |
Analyst sentiment
Institutional ownership
Screeners with QNRX
Data Sources & References
- QNRX Official Website quoinpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1671502/000110465925107785/0001104659-25-107785-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1671502/000141057825000336/0001410578-25-000336-index.htm
- QNRX Profile on Yahoo Finance finance.yahoo.com/quote/QNRX
- QNRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qnrx
FAQ
What is the ticker symbol for Quoin Pharmaceuticals, Ltd.?
The ticker symbol for Quoin Pharmaceuticals, Ltd. is NASDAQ:QNRX
Does Quoin Pharmaceuticals, Ltd. pay dividends?
No, Quoin Pharmaceuticals, Ltd. does not pay dividends
What sector is Quoin Pharmaceuticals, Ltd. in?
Quoin Pharmaceuticals, Ltd. is in the Healthcare sector
What industry is Quoin Pharmaceuticals, Ltd. in?
Quoin Pharmaceuticals, Ltd. is in the Biotechnology industry
What country is Quoin Pharmaceuticals, Ltd. based in?
Quoin Pharmaceuticals, Ltd. is headquartered in United States
When did Quoin Pharmaceuticals, Ltd. go public?
Quoin Pharmaceuticals, Ltd. initial public offering (IPO) was on August 1, 2016
Is Quoin Pharmaceuticals, Ltd. in the S&P 500?
No, Quoin Pharmaceuticals, Ltd. is not included in the S&P 500 index
Is Quoin Pharmaceuticals, Ltd. in the NASDAQ 100?
No, Quoin Pharmaceuticals, Ltd. is not included in the NASDAQ 100 index
Is Quoin Pharmaceuticals, Ltd. in the Dow Jones?
No, Quoin Pharmaceuticals, Ltd. is not included in the Dow Jones index
When was Quoin Pharmaceuticals, Ltd. last earnings report?
Quoin Pharmaceuticals, Ltd.'s most recent earnings report was on November 7, 2025
When does Quoin Pharmaceuticals, Ltd. report earnings?
The date for Quoin Pharmaceuticals, Ltd.'s next earnings report has not been announced yet